Andropause: Symptom management for prostate cancer patients treated with hormonal ablation

Research output: Contribution to journalReview articlepeer-review

73 Scopus citations


Andropause, or the age-related decline in serum testosterone, has become a popular topic in the medical literature over the past several years. Andropause includes a constellation of symptoms related to lack of androgens, including diminished libido, decreased generalized feeling of well-being, osteoporosis, and a host of other symptoms. The andropause syndrome is very prominent in men undergoing hormonal ablation therapy for prostate cancer. Most significant in this population are the side effects of hot flashes, anemia, gynecomastia, depression, cognitive decline, sarcopenia, a decreased overall quality of life, sexual dysfunction, and osteoporosis with subsequent bone fractures. The concept of andropause in prostate cancer patients is poorly represented in the literature. In this article, we review the current literature on the symptoms, signs, and possible therapies available to men who cannot take replacement testosterone.

Original languageEnglish (US)
Pages (from-to)474-487
Number of pages14
Issue number5
StatePublished - Oct 20 2003


  • Androgens
  • Antineoplastic agents, hormonal
  • Hot flashes
  • Impotence
  • Osteoporosis
  • Prostatic neoplasms
  • Quality of life

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Andropause: Symptom management for prostate cancer patients treated with hormonal ablation'. Together they form a unique fingerprint.

Cite this